Silence Therapeutics Plc (SLNCF)
2.63
+0.27
(+11.44%)
USD |
OTCM |
May 07, 09:30
Silence Therapeutics SG&A Expense (TTM) : 22.34M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Adaptimmune Therapeutics Plc | 90.50M |
| Biodexa Pharmaceuticals Plc | 6.375M |
| Oxford Biomedica Plc | 48.35M |
| NuCana Plc | 10.74M |
| Autolus Therapeutics Plc | 131.95M |